April 3, 2025 14:15

The majority stake in the U.S.-based manufacturer of injection molding machines and extruders, Milacron, has officially passed from industrial group Hillenbrand to private equity firm Bain Capital, in a transaction first announced in early February.

Along with the 51% ownership in Milacron, Bain Capital has also taken over the company’s  full operational control, while Hillenbrand received approximately $287 million from the transaction, including $250 million in net cash to reduce debt, and retains a 49% minority stake.

Hillenbrand acquired Milacron Holdings in 2019, which, in addition to molding and extrusion machinery, included Mold-Masters, DME and Cimcool. The latter was sold a year later, while Mold-Masters and DME remain in its portfolio.

In fiscal year 2024, Milacron reported revenue of $526 million and adjusted EBITDA of $64 million.

© Polimerica -  Reproduction prohibited, all rights reserved